Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Peptides derived from autoantigen for use in immunotherapy of autoimmue diseases

Peptides derived from autoantigen for use in immunotherapy of autoimmue diseases

US Patent 5736507 · Granted Apr 7, 1998

Estimated economic value: $2,156,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Humanized anti-SIRPα antibodies2024
Anti-SIRP α antibodies2023
Duocarmycin ADCs showing improved in vivo antitumor activity2022
Anti-SIRPα antibodies2022
Duocarmycin ADCs showing improved in vivo antitumor activity2020
Duocarmycin ADCS showing improved in vivo antitumor activity2016
Peptides for use in immunotherapy of autoimmune diseases2005
Peptides for use in immunotherapy of autoimmune diseases2005
Peptides suitable for use in antigen specific immunosuppressive therapy2005
Peptides suitable for use in antigen specific immunosuppressive therapy2001
Peptides suitable for use in antigen specific immunosuppressive therapy2001
Proteins and novel peptides derived from autoantigen for use in immunotherapy of1998